Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Melody

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Hematology/Oncology and Stem Cell Therapy|September 25, 2021
Predictors and Management of Relapse to Axicabtagene Ciloleucel in Patients with Aggressive B-cell LymphomaJose Vicente Forero-Forero, Paula A Lengerke-Diaz, Eider Moreno-Cortes, et al.
Hematology/Oncology and Stem Cell Therapy|October 18, 2020
C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucelMegan Melody, Zaid Abdel Rahman, Hollie Saunders, et al.
Leukemia & Lymphoma|August 27, 2021
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosisRami Komrokji, Megan Melody, Najla Al Ali, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|October 11, 2021
V.I.T.A.M. in COVID 19: A Systematic Approach to a Global PandemicSiva Naga S Yarrarapu, Pankaj Bansal, David Abia-Trujillo, et al.
Leukemia & Lymphoma|February 3, 2022
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experienceMegan Melody, Sangeetha Gandhi, Hollie Saunders, et al.
European Journal of Haematology|March 3, 2021
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucelMegan Melody, Sangeetha Gandhi, Zaid Abdel Rahman, et al.
Blood Advances|November 7, 2025
Outcomes for CART as 2L vs 3L vs 4L or Beyond in Aggressive B-cell Lymphoma: Real World Evidence from the ABC ConsortiumJohn Seng Wang, Brandon Lee Ellsworth, Megan Melody, et al.
JCO Oncology Practice|May 31, 2025
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF TrialVivek G Patel, Karine Tawagi, Samantha A Armstrong, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 5, 2026
Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF TrialRonak H Mistry, Karine Tawagi, Daniel J Hausrath, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Hematology/Oncology and Stem Cell Therapy|September 25, 2021
Predictors and Management of Relapse to Axicabtagene Ciloleucel in Patients with Aggressive B-cell LymphomaJose Vicente Forero-Forero, Paula A Lengerke-Diaz, Eider Moreno-Cortes, et al.
Hematology/Oncology and Stem Cell Therapy|October 18, 2020
C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucelMegan Melody, Zaid Abdel Rahman, Hollie Saunders, et al.
Leukemia & Lymphoma|August 27, 2021
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosisRami Komrokji, Megan Melody, Najla Al Ali, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|October 11, 2021
V.I.T.A.M. in COVID 19: A Systematic Approach to a Global PandemicSiva Naga S Yarrarapu, Pankaj Bansal, David Abia-Trujillo, et al.
Leukemia & Lymphoma|February 3, 2022
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experienceMegan Melody, Sangeetha Gandhi, Hollie Saunders, et al.
European Journal of Haematology|March 3, 2021
Impact of hypoalbuminemia on the prognosis of relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucelMegan Melody, Sangeetha Gandhi, Zaid Abdel Rahman, et al.
Blood Advances|November 7, 2025
Outcomes for CART as 2L vs 3L vs 4L or Beyond in Aggressive B-cell Lymphoma: Real World Evidence from the ABC ConsortiumJohn Seng Wang, Brandon Lee Ellsworth, Megan Melody, et al.
JCO Oncology Practice|May 31, 2025
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF TrialVivek G Patel, Karine Tawagi, Samantha A Armstrong, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 5, 2026
Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF TrialRonak H Mistry, Karine Tawagi, Daniel J Hausrath, et al.
Pageof 2